Condition: Femoral Fracture · Fragility Fracture · Muscle Atrophy · Sponsor: Michael C Willey
This trial will evaluate the impact of 4 weeks of postoperative essential amino acid (EAA)-based supplementation on muscle morphology after femoral fragility fracture. This trial will assess the ability of EAA-based to increase skeletal muscle metabolic activity, reduce inflammation, and induce muscle fiber hypertrophy, as well as preserve skeletal muscle mass and physical performance up to 6 months after injury. Participants will be randomized in a 1:1 ratio to 1) standard of care (no dietary intervention) or 2) EAA-based supplementation.
This description comes directly from the study's public registry record.
Michael C Willey, MD · 319-384-8452 · michael-willey@uiowa.edu
Ashley S Kochuyt, BS · 319-929-3559 · ashley-kochuyt@uiowa.edu
Always discuss trial participation with your own doctor first.
| University of Iowa Health Care | Iowa City, Iowa, United States | Recruiting |
| Slocum Center for Orthopedics & Sports Medicine | Eugene, Oregon, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06050668